Erika Cecchin

4.7k total citations
125 papers, 2.6k citations indexed

About

Erika Cecchin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erika Cecchin has authored 125 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 45 papers in Molecular Biology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erika Cecchin's work include Colorectal Cancer Treatments and Studies (43 papers), Cancer therapeutics and mechanisms (24 papers) and Pharmacogenetics and Drug Metabolism (23 papers). Erika Cecchin is often cited by papers focused on Colorectal Cancer Treatments and Studies (43 papers), Cancer therapeutics and mechanisms (24 papers) and Pharmacogenetics and Drug Metabolism (23 papers). Erika Cecchin collaborates with scholars based in Italy, United States and Ukraine. Erika Cecchin's co-authors include Giuseppe Toffoli, Elena De Mattia, Angela Buonadonna, Mario D’Andrea, Rossana Roncato, Giuseppe Corona, Paola Biason, Federico Innocenti, Jerry Polesel and Silvia Mezzalira and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Erika Cecchin

120 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika Cecchin Italy	27	1.5k	1.2k	409	406	363	125	2.6k
Theodore Karrison United States	26	1.1k 0.8×	927 0.8×	153 0.4×	486 1.2×	350 1.0×	64	2.6k
H. L. McLeod United States	21	1.1k 0.7×	677 0.6×	325 0.8×	216 0.5×	184 0.5×	60	1.8k
Fabienne Thomas France	26	829 0.6×	516 0.4×	180 0.4×	332 0.8×	163 0.4×	109	2.0k
Ina Koch Germany	18	689 0.5×	505 0.4×	621 1.5×	215 0.5×	143 0.4×	33	1.6k
Gamini S. Soori United States	23	1.6k 1.1×	428 0.4×	126 0.3×	642 1.6×	387 1.1×	70	2.6k
Rudolf Maibach Switzerland	33	1.6k 1.1×	697 0.6×	200 0.5×	864 2.1×	656 1.8×	73	3.7k
Yu Sunakawa Japan	25	1.2k 0.8×	465 0.4×	83 0.2×	518 1.3×	341 0.9×	183	1.8k
Masanori Kaneuchi Japan	32	642 0.4×	1.2k 1.0×	72 0.2×	306 0.8×	692 1.9×	92	3.3k
David Jamieson United Kingdom	20	731 0.5×	502 0.4×	101 0.2×	383 0.9×	217 0.6×	42	1.5k
Anne‐Lise Børresen Norway	21	1.0k 0.7×	1.1k 0.9×	167 0.4×	233 0.6×	680 1.9×	56	2.4k

Countries citing papers authored by Erika Cecchin

Since Specialization

Citations

This map shows the geographic impact of Erika Cecchin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Cecchin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Cecchin more than expected).

Fields of papers citing papers by Erika Cecchin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Cecchin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Cecchin. The network helps show where Erika Cecchin may publish in the future.

Co-authorship network of co-authors of Erika Cecchin

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Cecchin. A scholar is included among the top collaborators of Erika Cecchin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Cecchin. Erika Cecchin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gagno, Sara, Marcella Montico, Angela Buonadonna, et al.. (2025). Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devices. Journal of Chromatography B. 1255. 124526–124526. 2 indexed citations

Bramuzzo, Matteo, Erika Cecchin, Biljana Stanković, et al.. (2025). NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease. Biomedicine & Pharmacotherapy. 183. 117824–117824. 1 indexed citations

Gagno, Sara, Bianca Posocco, Michela Guardascione, et al.. (2024). Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series. Frontiers in Immunology. 15. 1441620–1441620. 2 indexed citations

Peruzzi, Elena, Rossana Roncato, Elena De Mattia, et al.. (2023). Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?. British Journal of Clinical Pharmacology. 91(2). 270–282. 8 indexed citations

Bignucolo, Alessia, et al.. (2022). Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers. Expert Review of Clinical Pharmacology. 15(6). 689–713. 2 indexed citations

Bignucolo, Alessia, et al.. (2022). Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC. Pharmaceutics. 14(11). 2468–2468. 3 indexed citations

Bignucolo, Alessia, et al.. (2021). Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Vaccines. 9(8). 825–825. 59 indexed citations

Mattia, Elena De, Jerry Polesel, Rossana Roncato, et al.. (2021). IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm. Cancers. 13(7). 1705–1705. 8 indexed citations

Etheridge, Amy S., Deborah A. Nickerson, Nancy J. Cox, et al.. (2021). Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. British Journal of Cancer. 126(4). 640–651. 8 indexed citations

10.

Etheridge, Amy S., Eleftheria Tsakalozou, Jacqueline Ramı́rez, et al.. (2020). Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. The AAPS Journal. 22(3). 59–59. 4 indexed citations

11.

Rampazzo, Enrica, Erika Cecchin, Paola Del Bianco, et al.. (2020). Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients. Cancers. 12(11). 3115–3115. 11 indexed citations

12.

Garziera, Marica, Rossana Roncato, Marcella Montico, et al.. (2019). New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach. Cells. 8(6). 584–584. 27 indexed citations

13.

Garziera, Marica, Erika Cecchin, Giorgio Giorda, et al.. (2019). Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC). Cells. 8(10). 1186–1186. 8 indexed citations

14.

Roncato, Rossana, Silvia Mezzalira, Elena De Mattia, et al.. (2019). FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy. Genes. 10(4). 276–276. 16 indexed citations

15.

Dreussi, Eva, Roberto Bortolus, Chiara Romualdi, et al.. (2019). rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy. International Journal of Molecular Sciences. 20(9). 2082–2082. 5 indexed citations

16.

Dugo, Matteo, Loris De Cecco, Erika Cecchin, et al.. (2019). Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study. Genes. 10(9). 678–678. 9 indexed citations

17.

Garziera, Marica, Erika Cecchin, Vincenzo Canzonieri, et al.. (2018). Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS). International Journal of Molecular Sciences. 19(5). 1510–1510. 14 indexed citations

18.

Mattia, Elena De, Eva Dreussi, Marcella Montico, et al.. (2018). A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy. Frontiers in Pharmacology. 9. 1101–1101. 5 indexed citations

19.

Garziera, Marica, Saverio Virdone, Elena De Mattia, et al.. (2017). HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 18(7). 1366–1366. 11 indexed citations

20.

Bignucolo, Alessia, Elena De Mattia, Erika Cecchin, Rossana Roncato, & Giuseppe Toffoli. (2017). Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment. International Journal of Molecular Sciences. 18(7). 1522–1522. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact